For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Elevance Health Inc (NYSE: ELV) closed the day trading at $347.84 down -0.69% from the previous closing price of $350.25. In other words, the price has decreased by -$0.69 from its previous closing price. On the day, 2.01 million shares were traded. ELV stock price reached its highest trading level at $357.24 during the session, while it also had its lowest trading level at $347.21.
Ratios:
For a better understanding of ELV, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.66.
On March 17, 2025, Argus Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $450.
Stephens Downgraded its Overweight to Equal-Weight on January 22, 2025, whereas the target price for the stock was revised from $520 to $440.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 24 ’25 when Kaye Mark sold 4,588 shares for $424.82 per share. The transaction valued at 1,949,074 led to the insider holds 18,977 shares of the business.
Kaye Mark bought 4,588 shares of ELV for $1,949,051 on Apr 24 ’25. On Mar 10 ’25, another insider, Penczek Ronald W, who serves as the CAO & Controller of the company, sold 443 shares for $415.13 each. As a result, the insider received 183,903 and left with 1,847 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELV now has a Market Capitalization of 78589231104 and an Enterprise Value of 84347518976. As of this moment, Elevance’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.57, and their Forward P/E ratio for the next fiscal year is 8.88. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.28. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.43 while its Price-to-Book (P/B) ratio in mrq is 1.85. Its current Enterprise Value per Revenue stands at 0.461 whereas that against EBITDA is 8.576.
Stock Price History:
The Beta on a monthly basis for ELV is 0.62, which has changed by -0.33939797 over the last 52 weeks, in comparison to a change of 0.12677538 over the same period for the S&P500. Over the past 52 weeks, ELV has reached a high of $567.26, while it has fallen to a 52-week low of $349.61. The 50-Day Moving Average of the stock is -11.09%, while the 200-Day Moving Average is calculated to be -15.94%.
Shares Statistics:
Over the past 3-months, ELV traded about 1.85M shares per day on average, while over the past 10 days, ELV traded about 2005270 shares per day. A total of 225.64M shares are outstanding, with a floating share count of 225.56M. Insiders hold about 0.17% of the company’s shares, while institutions hold 92.63% stake in the company. Shares short for ELV as of 1749772800 were 2503358 with a Short Ratio of 1.35, compared to 1747267200 on 2606814. Therefore, it implies a Short% of Shares Outstanding of 2503358 and a Short% of Float of 1.11.
Dividends & Splits
ELV’s forward annual dividend rate is 6.68, up from 6.6 a year ago. Against a Trailing Annual Dividend Yield of 0.018843682The stock’s 5-year Average Dividend Yield is 1.2. The current Payout Ratio is 25.39% for ELV, which recently paid a dividend on 2025-06-10 with an ex-dividend date of 1749513600. Stock splits for the company last occurred on 2005-06-01 when the company split stock in a 2:1 ratio.
